12:00 AM
Oct 01, 2012
 |  BC Week In Review  |  Company News  |  Deals

Melmed Holdings, Uluru deal

Uluru signed a binding term sheet to grant Melmed worldwide rights to commercialize Uluru's OraDisc transmucosal erodible film delivery technology for oral and dental applications. Uluru will have a 25% stake in a subsidiary that Melmed will establish to license the rights, plus 5% royalties on sales. Melmed will also receive...

Read the full 232 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >